Improving IBD outcomes and reducing disparities through everyday care, data, and education
Official title: RFA-DP-23-002, Improving Outcomes and Reducing Disparities for Patients with Inflammatory Bowel Disease through Epidemiology, Enhanced Disease Management, Dissemination, and Education
Funded at Univ of North Carolina Chapel Hill · NIH-11383272 · Data updated 2026-11-12
A multi-site program tests how social factors affect inflammatory bowel disease and whether new management and education can help people in diverse backgrounds feel better and stay healthier.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | September 30, 2023 |
| Project end | September 29, 2028 |
| Funding year | 2026 |
| Award (this year) | $774,997 |
| NIH project number | 5U01DP006745-04 |
| Project ID | NIH-11383272 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with Crohn’s disease or ulcerative colitis, including both children (13-17) and adults (>17) at participating sites.
✕Less likely to help
Patients not enrolled in the pragmatic trial or not experiencing social determinants affecting their care may see limited direct benefit.
What this research studies
This project follows people with Crohn’s disease and ulcerative colitis across multiple clinics to see how social circumstances influence disease progression and quality of life. It will test practical management strategies in real-world settings over a year and includes a large prospective group plus a built-in observational component. The effort also focuses on creating education for patients and clinicians that reflects what matters to diverse communities. The study is led by a team at UNC Chapel Hill and partners with pediatric and adult IBD centers to reach both children and adults.
Why it matters
Potential benefit: If successful, the program could reduce disparities in IBD care and improve daily living and outcomes for patients from diverse backgrounds.
How similar studies have gone: Prior studies suggest social factors influence IBD outcomes; this project builds on that by testing real-world management and education approaches.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Kappelman, Michael D — Univ of North Carolina Chapel Hill
- Study coordinator: Kappelman, Michael D
Related research
Other NIH-funded projects on the same topics.
-
Mitochondrial Talks: How Energy Networks Shape Inflammatory Bowel Disease
Aimed at people with inflammatory bowel disease (IBD), this project explores how tiny cell powerhouses in the gut may go out of balance and contribute to IBD, with the goal of restoring energy and reducing disease symptoms.
-
Mn in inflammatory bowel disease: how manganese and genes may shape gut inflammation
This grant studies how the mineral manganese and a specific gene variant may influence inflammatory bowel disease in people of different ages.
-
AI-Enhanced Virtual Reality CBT to Reduce Anxiety for IBD Patients
A home-based VR and AI-powered cognitive behavioral therapy program is being tested to help people with inflammatory bowel disease feel less anxious and improve their quality of life.
-
Gasdermin-based epithelial function in inflammatory bowel disease
A funding opportunity that explores how gasdermin proteins affect the lining of the gut and may influence inflammatory bowel disease.
-
Intestinal chondroitin sulfate glycosaminoglycans and their role in inflammatory bowel disease
A clinician-scientist mentoring program aims to advance understanding of how intestinal sugar molecules called chondroitin sulfate glycosaminoglycans influence inflammatory bowel disease and patient care.
-
Improving IBD outcomes through community awareness, referrals, and education
A U01 grant will support programs to raise awareness, improve referrals, and educate patients and clinicians about inflammatory bowel disease to improve diagnosis and care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.